PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
27-Jun-2024 The Danish Medicines Council recommends CSL Behring’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B CSL Behring
27-Jun-2024 CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital CatSci Ltd
27-Jun-2024 Fostrox + Lenvima® holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI Medivir AB
27-Jun-2024 CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) CalciMedica Inc
27-Jun-2024 SMART Researchers Pioneer Production of CAR T-Cells Using High-Density Microfluidic Bioreactor SMART
26-Jun-2024 Discovery Park Innovation Summit showcases Kent’s ambition to be a leader in healthy ageing Discovery Park
26-Jun-2024 EDX MEDICAL TO MARKET PIONEERING CANCER DRUGS RESPONSE ASSAY IN UK AND NORDICS EDX Medical Group
26-Jun-2024 Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models Ikerian AG
25-Jun-2024 Engitix appoints two additional international biotech industry leaders as Scientific Advisors Engitix Ltd
25-Jun-2024 Emmes partners with ILiAD Biotechnologies to Conduct Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine ILiAD Biotechnologies, LLC
25-Jun-2024 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda HUTCHMED
25-Jun-2024 Senzime granted new European TetraGraph system patent Senzime
25-Jun-2024 Linus Health Introduces Person-Centered Approach to Establish Clinically Meaningful Benefits and Personalized Brain Health Care Linus Health
25-Jun-2024 FDB Vela™ and RxEOB® Deliver Transparent Pricing and Pharmacy Options to Consumers to Inform Choice and Savings on Medications FDB
24-Jun-2024 Integrated DNA Technologies Introduces New HIV Panel to Advance Virology Research Integrated DNA Technologies
21-Jun-2024 Revealed: UK Drug Companies Repeatedly Violate their Marketing Code, warns research from the University of Bath and Lund University University of Bath and Lund University academics
21-Jun-2024 4SC AG: AGM highlights - Positive progress in 2023/2024 leaves company well positioned for resminostat commercialisation 4SC AG
20-Jun-2024 Yellowstone Biosciences launches with £16.5 million to pioneer soluble bispecific TCR-based therapies for cancer Yellowstone Biosciences
20-Jun-2024 Syncona adds two new oncology companies to its portfolio Syncona Limited
20-Jun-2024 Sound Bioventures expands portfolio with new investment in US company NephroDI Therapeutics to accelerate development of NDI-5001 for pediatric orphan kidney disease Sound Bioventures